Company Filing History:
Years Active: 2017
Introduction
Mark R Benmuvhar is an accomplished inventor based in St. Louis, MO. With a focus on innovative pharmaceutical technologies, Benmuvhar has made significant contributions to the field of drug delivery systems. His work not only emphasizes the importance of effective pharmaceutical formulations but also enhances the accessibility and effectiveness of medications.
Latest Patents
Benmuvhar holds a patent for a "Matrix-based pulse release pharmaceutical formulation." This innovative oral composition features a polymer matrix core, designed to distribute at least one pharmaceutically active ingredient both within the core and on its outer surface. This formulation can include amphetamine salts among other active ingredients, presenting a novel approach to pharmaceutical composition. The patent also details a method for creating an immediate release component within a solid pharmaceutical formulation, showcasing the advancement in drug delivery techniques.
Career Highlights
Mark R Benmuvhar is associated with Mallinckrodt, Inc., a leader in specialty pharmaceuticals. His contributions within the company highlight his expertise in the development of advanced pharmaceutical products. Benmuvhar's educational background and professional journey have equipped him with the skills necessary to innovate in such a challenging and regulated industry.
Collaborations
Throughout his career, Benmuvhar has collaborated with notable colleagues, including Ashwini Gadre and Brian Kai-Ming Cheng. These partnerships have fostered an environment of shared knowledge and have further propelled advancements in pharmaceutical formulation technologies.
Conclusion
Mark R Benmuvhar's work exemplifies ingenuity in pharmaceutical innovations. His patented matrix-based pulse release formulation represents a significant step forward in medication delivery, reflecting his commitment to improving patient outcomes. As a dedicated inventor, Benmuvhar continues to explore new avenues in drug formulation, setting the stage for future advancements in the pharmaceutical industry.